Yang L, Cao L, Zhang X, Chu B (2022a) Targeting ferroptosis as a vulnerability in pulmonary diseases
The time-to-event model also suggested that fasting glucose, systolic blood pressure, total cholesterol and triglycerides would return to baseline levels within a year of drug cessation, while HbA 1c and diastolic blood pressure were predicted to return to baseline by 1.4 years
Clinical trial participants experienced weight reduction of up to 12.4%
In terms of safety, the overall rate of adverse events was highest with semaglutide 2.4 mg, followed by liraglutide 3.0 mg, liraglutide 1.8 mg, and semaglutide 1.0m g, compared to placebo
Maintenance strategy: Microdosing can serve as a maintenance dose after achieving goal weight
showed that ADM levels are significantly elevated in sepsis and septic shock compared with non-septic patients